AR and breast carcinoma: Huang et al. built a regression analysis-based risk model to highlight a cluster of androgen-receptor signaling-pathway-related long non-coding RNAs (ARSP-related lncRNAs) that were strongly linked with the incidence and progression of breast cancer and were demonstrated to effectively predict the prognoses of breast cancer patients [151].